Benzene

Benzene

SCHEMBL249062

O=S(=O)(O)O.c1ccccc1

nearest known ligand 0.67

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

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

The experimentally established mechanism targets of Benzene. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA5A P35218 2/20 0.67
CA5B Q9Y2D0 2/20 0.67
TSHR P16473 5/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
CA2 P00918 3/20 0.42
CA1 P00915 2/20 0.42
TDP1 Q9NUW8 2/20 0.42
NT5E P21589 1/20 0.42
CA4 P22748 1/20 0.42
CA6 P23280 1/20 0.42
CA7 P43166 1/20 0.42
CA9 Q16790 1/20 0.42
KDM4E B2RXH2 4/20 0.40
BLM P54132 2/20 0.40
ALDH1A1 P00352 4/20 0.39
KMT2A Q03164 2/20 0.39
MEN1 O00255 1/20 0.39
MAPT P10636 3/20 0.38
HPGD P15428 2/20 0.38
LMNA P02545 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Benzene SCHEMBL9118283 1.00 CA5A (0.67) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL29238660 1.00 CA5A (0.67) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL28815094 1.00 CA5A (0.67) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL10354042 1.00 CA5A (0.67) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL3380499 1.00 CA5A (0.67) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL10575327 0.95 CA5A (0.60) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL9821129 0.95 CA5A (0.60) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL6363798 0.95 CA5A (0.60) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL11215425 0.95 CA5A (0.60) CA5ACA5BTSHRSMN1; SMN2CA2
Benzene SCHEMBL29071467 0.95 CA5A (0.60) CA5ACA5BTSHRSMN1; SMN2CA2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 996 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118632695-A Nilapatinib and abiraterone acetate Long Jiapo are useful for improving clinical outcome in patients with metastatic castration-resistant prostate cancer and HRR alterations 詹森药业有限公司 2024-09-10 CN claimed
EP-4373491-A1 TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH NIRAPARIB JANSSEN Pharmaceutica NV (BE) 2024-05-29 EP claimed
CN-117715643-A Treatment of metastatic castration-resistant prostate cancer with nilaparib 詹森药业有限公司 2024-03-15 CN claimed
CN-115124978-B Gas drainage borehole gel hole sealing material and preparation method thereof 湖南科技大学 2023-09-01 CN claimed
WO-2023148345-A1 NIRAPARIB AND ABIRATERONE ACETATE PLUS PREDNISONE TO IMPROVE CLINICAL OUTCOMES IN PATIENTS WITH METASTATIC CASTRATION-RESISTANT PROSTATE CANCER AND HRR ALTERATIONS JANSSEN PHARMACEUTICA NV (BE) 2023-08-10 WO claimed
EP-4146211-A1 PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND NIRAPARIB JANSSEN Pharmaceutica NV (BE) 2023-03-15 EP claimed
WO-2023001746-A1 TREATMENT OF METASTATIC CASTRATION-RESISTANT PROSTATE CANCER WITH NIRAPARIB JANSSEN PHARMACEUTICA NV (BE) 2023-01-26 WO claimed
US-11208559-B2 Modified indigo compounds and methods of dyeing a substrate using a modified indigo compound THE H.D. LEE COMPANY, INC. (US) 2021-12-28 US claimed
WO-2021224471-A1 PHARMACEUTICAL FORMULATIONS OF ABIRATERONE ACETATE AND NIRAPARIB JANSSEN PHARMACEUTICA NV (BE) 2021-11-11 WO claimed
EP-3200754-B1 COSMETIC PROCESS FOR ATTENUATING WRINKLES OREAL (FR) 2020-06-10 EP claimed
EP-0731687-B1 HAIR CLEANING AND/OR CARE AGENT AND PROCESS FOR PRODUCING IT PETRITSCH ERICH (AT) 2001-03-07 EP claimed
EP-0322858-B1 A method for measuring the amount of polyamines in a biological sample TOYO BOSEKI (JP) 1994-08-31 EP claimed
EP-0393713-B1 Process for the preparation of N-substituted maleimides TOSOH CORP (JP) 1994-06-29 EP claimed
US-RE34606-E Modified enzymes and methods for making same GENENCOR, INC. (US) 1994-05-10 US claimed
US-5091350-A Extracting with aqueous solution of organic phosphine sulfonate or carboxylate and solubilizer HOECHST AKTIENGESELLSCHAFT (DE) 1992-02-25 US claimed
US-5087705-A Heating N-substituted maleamic acid monoester in presence of acid catalyst SHIN-DAIKYOWA PETROCHEMICAL CO., LTD. (JP) 1992-02-11 US claimed
EP-0393713-A1 Process for the preparation of N-substituted maleimides Tosoh Corporation (JP) 1990-10-24 EP claimed
US-4731485-A Process for hydroformylation with rhodium catalysts and the separation of rhodium therefrom RUHRCHEMIE AKTIENGESELLSCHAFT (DE) 1988-03-15 US claimed
EP-0102271-B1 PROCESS FOR THE STABILISATION OF REACTIVE IMINES, STABLE IMINIUM SALTS OBTAINED BY THIS PROCESS AND THEIR USE CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE (CNRS) (FR) 1986-01-08 EP claimed
US-4311512-A Bactericidal water-soluble complexes POLYCRAFT LABORATORIES, INC., A CORP. OF NJ. 1982-01-19 US claimed